ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
4.200
-0.150 (-3.45%)
At close: Mar 27, 2024, 4:00 PM
4.370
+0.170 (4.05%)
Pre-market: Mar 28, 2024, 7:29 AM EDT

ADC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
278.6326.44466.54439.2115.55138.81
Cash & Cash Equivalents
278.6326.44466.54439.2115.55138.81
Cash Growth
-14.66%-30.03%6.23%280.09%-16.75%-
Receivables
25.1872.9730.22000.19
Inventory
16.1812.0711.12000
Other Current Assets
16.3323.517.311.267.063.08
Total Current Assets
336.29434.98525.18450.45122.61142.08
Property, Plant & Equipment
16.1310.2611.234.766.271.54
Long-Term Investments
1.657.6141.2447.9100
Goodwill and Intangibles
0013.5810.188.436.67
Other Long-Term Assets
0.7138.0126.740.40.370.26
Total Long-Term Assets
18.4955.8892.7963.2415.088.48
Total Assets
354.78490.86617.97513.69137.68150.56
Accounts Payable
15.5712.3512.085.283.336.75
Deferred Revenue
000002.34
Current Debt
1.471.17.64.631.130
Other Current Liabilities
50.6368.4954.2530.5215.4813.26
Total Current Liabilities
67.6781.9473.9440.4419.9422.35
Long-Term Debt
122.91116.28132.09110.453.90
Other Long-Term Liabilities
312.45213.19245.8627.32.681.96
Total Long-Term Liabilities
435.36329.47377.95137.756.581.96
Total Liabilities
503.03411.41451.88178.1926.5324.32
Total Debt
124.38117.38139.7115.085.030
Debt Growth
5.97%-15.98%21.39%2187.44%--
Retained Earnings
-1,335.47-1,095.42-924.89-694.86-448.57-332.09
Comprehensive Income
-0.091.820.180.250.07-0.04
Shareholders' Equity
-148.2579.45166.09335.51111.16126.24
Net Cash / Debt
154.22209.07326.85324.11110.52138.81
Net Cash / Debt Growth
-26.23%-36.04%0.84%193.26%-20.38%-
Net Cash Per Share
1.892.68----
Working Capital
268.62353.04451.25410.01102.66119.73
Book Value Per Share
-1.811.022.164.731.66-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).